openPR Logo
Press release

Clinical Trials Management System Market Top Players - Oracle; DATATRAK International, Inc.; Clario; SimpleTrials; Calyx; RealTime Software Solutions.

07-23-2025 07:58 AM CET | Health & Medicine

Press release from: Insightace Analytic Pvt Ltd.

Clinical Trials Management System Market

Clinical Trials Management System Market

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Clinical Trials Management System Market Size, Share & Trends Analysis Report By Solution Type (Enterprise and Site based), By Delivery Mode (Web & Cloud-based, On-premise), By Component (Software, Services), By End-user (Pharmaceutical and Biotechnology Firms, Medical Device Firms, CROs)- Market Outlook And Industry Analysis 2034"

The global Clinical Trials Management System market is estimated to reach over 7.3 billion by the year 2034 , exhibiting a CAGR of 13.7% during the forecast period.

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1684

The clinical trial management systems (CTMS) market is experiencing substantial growth, primarily driven by the rising prevalence of chronic and lifestyle-related diseases, as well as the growing trend of outsourcing clinical trials to contract research organizations (CROs). According to the Alzheimer's Association (2021), Alzheimer's dementia disproportionately affects the elderly population in the United States, with prevalence rates of 5.3% among individuals aged 65-74, 13.8% among those aged 75-84, and 34.6% among those 85 and older. The increasing burden of such chronic illnesses is expected to fuel the demand for specialized clinical trials, thereby driving the adoption of CTMS solutions and supporting overall market expansion.

Furthermore, the CTMS market is benefiting from significant research and development (R&D) investments by pharmaceutical and biopharmaceutical companies. As reported by the European Federation of Pharmaceutical Industries and Associations (EFPIA) in 2022, R&D expenditures in 2020 totaled approximately EUR 39.7 billion in Europe, USD 72.4 billion in the United States, and CNY 78.5 billion in China.

These investments are instrumental in advancing clinical trial initiatives, leading to increased utilization of CTMS platforms. Additionally, technological advancements aimed at optimizing trial management and reducing associated costs continue to strengthen market growth. For instance, in September 2021, Total Clinical Trial Management (TCTM) launched the "TOTAL Diversity" initiative, underscoring the industry's ongoing efforts to improve efficiency and cost-effectiveness in clinical research operations.

List of Prominent Players in the Clinical Trials Management System Market:
• IQVIA Inc.;
• Medidata (Dassault Systèmes);
• Oracle;
• DATATRAK International, Inc.;
• Clario
• SimpleTrials;
• Calyx;
• RealTime Software Solutions, LLC;
• Laboratory Corporation of America Holdings;
• Veeva Systems; Wipro Limited;
• PHARMASEAL International Ltd

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-01

Market Dynamics
Drivers:
The clinical trial management systems (CTMS) market is expected to witness robust growth, primarily driven by the increasing implementation of decentralized clinical trials (DCTs). These trials utilize telemedicine and other digital health technologies and are often referred to as virtual, mobile, remote, or siteless trials. A key example includes Labcorp's DCT offering, which delivers a comprehensive infrastructure, advanced technology solutions, and support services designed to streamline the design and execution of decentralized trials. Additionally, the availability of advanced CTMS platforms from leading market players is further propelling adoption. For instance, Medidata's Rave CTMS offers a comprehensive automation and workflow management solution that enhances operational efficiency and monitoring of clinical trials.

Challenges:
While the market outlook remains positive, data privacy and cybersecurity concerns present notable challenges. The integration of cloud computing and big data analytics into CTMS platforms brings operational and cost benefits but also increases the risk of data breaches and compliance issues. As a result, the implementation of robust data protection frameworks and adherence to regulatory standards are essential for mitigating these risks and ensuring secure clinical trial operations.

Regional Trends:
North America, particularly the United States, remains the leading regional market for CTMS, driven by substantial investment in research and development and a strong demand for novel therapeutic solutions. According to data from ClinicalTrials.gov, as of July 2022, North America accounted for 173,066 active clinical trials, with the United States alone representing 155,448 of these. This high volume of research activity, coupled with sustained financial support for clinical innovation, is expected to continue driving CTMS market growth across the region.

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/1684

Recent Developments:
• In March 2022, THREAD and Amazon Web Services agreed to work together. AWS will help develop new THREAD platform features by providing scalable automation and integrated AI to enable quicker and more effective trials by enabling higher quality data collecting throughout the clinical study lifecycle.

Segmentation of Clinical Trials Management System Market-
By Solution Type-
• Enterprise
• Site
By Delivery Mode-
• Web & Cloud-based
• On-premise
By Component-
• Software
• Services
By End User-
• Pharmaceutical and Biotechnology Firms
• Medical Device Firms
• CROs & Others
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa

View Overview Report: https://www.insightaceanalytic.com/report/clinical-trials-management-system-market/1684

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 607 400-7072
Asia: +91 79 72967118
info@insightaceanalytic.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Clinical Trials Management System Market Top Players - Oracle; DATATRAK International, Inc.; Clario; SimpleTrials; Calyx; RealTime Software Solutions. here

News-ID: 4115338 • Views:

More Releases from Insightace Analytic Pvt Ltd.

Automotive Lead Acid Battery Market Strategic Growth Drivers and Outlook 2026 to 2035
Automotive Lead Acid Battery Market Strategic Growth Drivers and Outlook 2026 to …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Automotive Lead Acid Battery Market Size, Share & Trends Analysis Report By Product (SLI and Micro-Hybrid Batteries), Type (Flooded, Enhanced Flooded, and VRLA), Customer Segment (OEM and Aftermarket), End User (Passenger Car, Light Commercial Vehicles, Heavy Commercial Vehicles, Two-Wheeler, and Three-Wheeler), and Application (Hybrid Vehicles, Electric Vehicles, Light Motor Vehicles, and Heavy Motor Vehicles)- Market
Automotive Interior Market Investment Opportunities and Forecast 2026 to 2035
Automotive Interior Market Investment Opportunities and Forecast 2026 to 2035
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Automotive Interior Market- (By Component Type (Center Stack, Head-up Display, Instrument Cluster, Rear Sear Entertainment, Dome Module, Headliner, Seat, Interior Lighting Door Panel, Center Console, Adhesives & Tapes, Upholstery, Others), By Material (Leather, Fabric, Vinyl, Wood, Glass Fiber Composite, Carbon Fiber Composite, Metal), By Level of Autonomy (Semi-Autonomous, Autonomous, Non-Autonomous),By Electric Vehicle (Battery Electric Vehicle
Artificial General Intelligence Market Future Landscape and Industry Evolution 2026 to 2035
Artificial General Intelligence Market Future Landscape and Industry Evolution 2 …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Artificial General Intelligence (AGI) Market - (By Type of Offering (Hardware, Software and Service), Type of Technology (Machine Learning, Deep Learning, Natural Language Processing and Robotics), Mode of Deployment (Cloud-based, On Premise and Web-based), Type of AI (Weak AI, Strong AI and Superintelligence), Type of Processing (Image, Text and Voice Processing), Company Size (SMEs and
Allogenic Cell Therapies Market Revenue Trends and Growth Potential 2026 to 2035
Allogenic Cell Therapies Market Revenue Trends and Growth Potential 2026 to 2035
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Allogenic Cell Therapies Market- by Cell Type(Cardiosphere-Derived Cells (CDCs), Fibroblasts, T-cells, Mesenchymal Stem Cells (MSCs), Hematopoietic Stem Cells (HSCs) and Others),Tissue Source(Skin, Blood, PBC, BM and Others), Indication (Acute graft-versus-host disease (GVHD), Chronic Ulcers and Diabetic Foot Ulcers, Osteoarthritis, Crohn's Disease, Cardiovascular Disease, Solid Tumors/Cancers and Others (Alzheimer's Disease, etc.)), Trends, Industry Competition Analysis, Revenue

All 5 Releases


More Releases for Trial

Clinical Trial Investigative Site Network Market Clinical Trial Investigative Si …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Clinical Trial Investigative Site Network Market - (By Therapeutic Areas (Oncology, Cardiology, CNS, Pain Management, Endocrine, Others), By Phase (Phase I, Phase II, Phase III, Phase IV), By End-use (Sponsor, CRO)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034." According to the latest research by InsightAce Analytic, the Global Clinical Trial Investigative Site Network Market
Transformative Trends Impacting the Electronic Trial Master File (eTMF) Systems …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Electronic Trial Master File (eTMF) Systems Market Size By 2025? The market size of the electronic trial master file (eTMF) systems has experienced fast growth over recent years. The market is projected to increase from $1.36 billion in 2024 to $1.55 billion in 2025, with
Transformative Trends Impacting the Electronic Trial Master File (eTMF) Systems …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Electronic Trial Master File (eTMF) Systems Market Size By 2025? The market size of the electronic trial master file (eTMF) systems has experienced fast growth over recent years. The market is projected to increase from $1.36 billion in 2024 to $1.55 billion in 2025, with
Clinical Trial Imaging market
The Clinical Trial Imaging market crossed the US$ 1.09 billion mark in 2022 and is expected to hit US$ 1.94 billion by 2030, recording a CAGR of 7.5% during the forecast period. Rising R&D spending, a rapidly growing pharmaceutical industry, and an increase in the number of contract research organizations are some of the major factors driving the market's growth. There has been an increase in pharmaceutical companies due to the
Clinical Trial Logistics
Clinical Trial Logistics 16th to 17th May 2011, Marriott Regents Park, London, United Kingdom. It currently costs just over £500 million ($800 million) to bring a new chemical to market and development timelines continue to fall in the 10-15 year range. A key reason for high R&D costs is due to logistical failures including failure to recruit patients on time. A way to avoid this is to move clinical trials
Clinical Trial Logistics
Announcing SMi's 5th annual… Clinical Trial Logistics conference 16th and 17th May 2011, Central London, UK www.smi-online.co.uk/2011logistics-london6.asp It currently costs just over £500 million ($800 million) to bring a new chemical to market and development timelines continue to fall in the 10-15 year range. A key reason for high R&D costs is due to logistical failures including failure to recruit patients on time. A way to avoid this is to move clinical